Consolidation (business)

ATMOFIZER TECHNOLOGIES INC. ANNOUNCES SHARE CONSOLIDATION

Retrieved on:

Wednesday, January 4, 2023

SEDAR, Atmosphere, Indian stock exchange, Intellectual property, Canada Business Corporations Act, Health, Patent, CSE, Consolidation (business), Risk, COVID-19, Nature, News, Virus, HEPA, OTCQB, Consolidation, Bacteria, Risk management

VANCOUVER, BC, Jan. 3, 2023 /PRNewswire/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (Frankfurt: J3K) (OTCQB: ATMFF) announces that the board of directors of the Company has approved a share consolidation of the Company's common shares ("Common Shares") on a twenty (20) for one (1) basis (the "Consolidation").

Key Points:

VANCOUVER, BC, Jan. 3, 2023 /PRNewswire/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (Frankfurt: J3K) (OTCQB: ATMFF) announces that the board of directors of the Company has approved a share consolidation of the Company's common shares ("Common Shares") on a twenty (20) for one (1) basis (the "Consolidation").
Following Consolidation and subject to rounding, it is expected that the Company will have 6,687,390 Common Shares issued and outstanding on a non-diluted basis.
Pursuant to the Business Corporations Act (British Columbia) and the articles of the Company, shareholder approval is not required for the Consolidation and therefore, the Company will not be seeking shareholder approval for the Consolidation.
Atmofizer plans to disrupt the air treatment industry by improving air safety and purification efficiency while lowering customers' operational costs.

Victory Square Announces Closing of Qualifying Transaction Involving Its Former Subsidiary, IV Hydreight, and Anticipated Trading Date for Resulting Issuer Shares

Retrieved on:

Tuesday, November 29, 2022

VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) ("VST" or the "Company") is pleased to announce that, further to its news release dated July 13, 2022, the reverse takeover transaction (the "Transaction") pursuant to a merger agreement dated effective July 12, 2022, as amended (the "Merger Agreement"), between the Company, IV Hydreight Inc. ("Hydreight"), Hydreight Technologies Inc. (formerly Perihelion Capital Ltd.) ("NURS"), 1362795 B.C. Ltd. ("AssetCo"), and 1203500 B.C. Ltd., a wholly-owned subsidiary of NURS, has completed.

Key Points:

Additionally, NURS issued 1,394,841 NURS Shares at a deemed price of $0.63 per share to a third party as a finders fee for the Transaction.
Certain NURS Shares are subject to escrow pursuant to the policies of the TSX Venture Exchange (the "Exchange").
It is anticipated that the NURS Shares will resume trading on the Exchange under the trading symbol "NURS" on or about December 1, 2022.
Pursuant to the Transaction, VST sold its interest in Hydreight and now owns approximately 73.72% of the issued and outstanding NURS Shares.

PlantX Life to acquire online domain veganessentials.com

Retrieved on:

Monday, September 19, 2022

VANCOUVER, BC, Sept. 19, 2022 /PRNewswire/ - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("PlantX" or the "Company"), the digital face of the plant-based community, operating a one-stop shop for plant-based products, is pleased to announced that it will acquire the online domain www.veganessentials.com , and certain associated intellectual property and assets.

Key Points:

VANCOUVER, BC, Sept. 19, 2022 /PRNewswire/ - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("PlantX" or the "Company"), the digital face of the plant-based community, operating a one-stop shop for plant-based products, is pleased to announced that it will acquire the online domain www.veganessentials.com , and certain associated intellectual property and assets.
Vegan Essentials was awarded best online vegan store from 2005-2018 and best online vegan grocery from 2018-2021, by VegNews Magazine.
"The acquisition is expected to build upon and complement the significant portfolio of e-commerce websites at PlantX which serve the plant-based community", said PlantX Chief Marketing Officer, Alex Hoffman.
"PlantX expects to provide existing content and promote existing products, through this domain name, with limited investment of incremental employees or infrastructure".

BLUERUSH ANNOUNCES COMPLETION OF PRIVATE PLACEMENT OF CONVERTIBLE DEBENTURE UNITS

Retrieved on:

Wednesday, August 10, 2022

TORONTO, Aug. 10, 2022 /PRNewswire/ - BlueRush Inc. ("BlueRush" or the "Company") (TSXV: BTV) (OTCQB: BTVRF), an emerging personalized video creation Software as a Service company, is pleased to announce the completion of its previously announced non-brokered private placement financing (the "Offering") of convertible debenture units (the "Convertible Debenture Units").

Key Points:

TORONTO, Aug. 10, 2022 /PRNewswire/ - BlueRush Inc. ("BlueRush" or the "Company") (TSXV: BTV) (OTCQB: BTVRF), an emerging personalized video creation Software as a Service company, is pleased to announce the completion of its previously announced non-brokered private placement financing (the "Offering") of convertible debenture units (the "Convertible Debenture Units").
Pursuant to the Offering, the Company raised gross proceeds of US$3,023,995 through the issuance of Convertible Debenture Units consisting of 10.0% unsecured convertible debentures (the "Convertible Debentures") for an aggregate principal amount of US$3,023,995 and an aggregate of 37,812,500 common share purchase warrants (the "Warrants").
The Convertible Debentures and the Warrants forming part of the Convertible Debenture Units, and any securities issuable upon conversion or exercise thereof, will be subject to a statutory hold period of four months and one day from the date of issuance of the Convertible Debenture Units.
IndiVideo enables BlueRush clients to capture knowledge and data from their customers' video interaction, creating new and compelling data driven customer insights.

RETRANSMISSION: HIVE Blockchain Announces 5 to 1 Share Consolidation Effective at Market Open May 24, 2022

Retrieved on:

Tuesday, May 24, 2022

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated February 2, 2021 to its amended and restated short form base shelf prospectus dated January 4, 2022.

Key Points:

The Common Shares will commence trading on the TSX Venture Exchange ("TSXV") and Nasdaq on a post-Consolidation basis effective at market opening on May 24, 2022.
No action is required by non-registered shareholders (shareholders who hold their common shares through an intermediary) to affect the Consolidation.
Consequently, holders of HIVE Warrants will be entitled to receive one (1) post-Share Consolidation Common Share upon exercising five (5) HIVE Warrants and paying an aggregate of CAD$30.00.
"Despite our record profitability, HIVE shares trade at around a 2.2 P/E ratio as of May 23, 2022.

HIVE Blockchain Announces 5 to 1 Share Consolidation Effective at Market Open May 24, 2022

Retrieved on:

Tuesday, May 24, 2022

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated February 2, 2021 to its amended and restated short form base shelf prospectus dated January 4, 2022.

Key Points:

The Common Shares will commence trading on the TSX Venture Exchange ("TSXV") and Nasdaq on a post-Consolidation basis effective at market opening on May 24, 2022.
No action is required by non-registered shareholders (shareholders who hold their common shares through an intermediary) to affect the Consolidation.
Consequently, holders of HIVE Warrants will be entitled to receive one (1) post-Share Consolidation Common Share upon exercising five (5) HIVE Warrants and paying an aggregate of CAD$30.00.
"Despite our record profitability, HIVE shares trade at around a 2.2 P/E ratio as of May 23, 2022.

Mydecine Announces First Quarter 2022 Financial Results and Highlights

Retrieved on:

Tuesday, May 17, 2022

DENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (Mydecine or the Company), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financial results and provided a business update for the first quarter of 2022.

Key Points:

DENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (Mydecine or the Company), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financial results and provided a business update for the first quarter of 2022.
Our team had an extremely productive first quarter, said Mydecine CEO Josh Bartch.
Management has been working diligently to decrease expenses and increase efficiencies, setting Mydecine up for future success.
Following March 31, 2022, as announced on April 27, 2022 and May 2, 2022, the Company raised an additional $1.65 million in financing.

Harborside Inc. Reports Fourth Quarter 2021 Financial Results

Retrieved on:

Thursday, April 28, 2022

OAKLAND, Calif. and TORONTO, April 27, 2022 /PRNewswire/ - Harborside Inc. ("Harborside" or the "Company") (CNSX: HBOR), (OTCQX: HBORF), a California-focused, vertically integrated cannabis enterprise, today filed its audited annual financial statements and management's discussion & analysis for the twelve months ended December 31, 2021 (collectively, the "Annual Financial Results") under the Company's profile on SEDAR at www.sedar.com .

Key Points:

OAKLAND, Calif. and TORONTO, April 27, 2022 /PRNewswire/ - Harborside Inc. ("Harborside" or the "Company") (CNSX: HBOR), (OTCQX: HBORF), a California-focused, vertically integrated cannabis enterprise, today filed its audited annual financial statements and management's discussion & analysis for the twelve months ended December 31, 2021 (collectively, the "Annual Financial Results") under the Company's profile on SEDAR at www.sedar.com .
The Annual Financial Results encompass a period prior to the Company's acquisitions of UL Holdings Inc. ("Urbn Leaf") and LPF JV Corporation ("Loudpack"), which were completed in March and April 2022, respectively.
Accordingly, following the Name Change and Consolidation, shareholders currently holding six Shares of Harborside will instead own one Share of StateHouse Holdings Inc.
Founded in 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States.

Electra Confirms Effective Date for Share Consolidation

Retrieved on:

Monday, April 11, 2022

TORONTO, April 11, 2022 /PRNewswire/ - Electra Battery Materials Corporation (TSXV: ELBM) (OTCQX: ELBMF)("Electra" or the "Company") announces that effective at the close of business on April 12, 2022, the Company will consolidate (the "Consolidation") its outstanding common share capital on the basis of one (1) post-Consolidation share for every eighteen (18) pre-Consolidation shares.

Key Points:

TORONTO, April 11, 2022 /PRNewswire/ - Electra Battery Materials Corporation (TSXV: ELBM) (OTCQX: ELBMF)("Electra" or the "Company") announces that effective at the close of business on April 12, 2022, the Company will consolidate (the "Consolidation") its outstanding common share capital on the basis of one (1) post-Consolidation share for every eighteen (18) pre-Consolidation shares.
The Consolidation was previously approved by shareholders of the Company at the annual general and special meeting held on December 2, 2021.
As of the date of this news release, the Company has 562,414,189 common shares issued and outstanding.
Following completion of the Consolidation, the Company is expected to have approximately 31,245,233 common shares issued and outstanding.

Lithium Ionic Inc. and POCML 6 Inc. Announce Closing of Upsized $14M Subscription Receipt Offering

Retrieved on:

Tuesday, February 8, 2022

Lithium, Agency agreement, Issuer, Miller Thomson, Agent, Agency, Sale, Trust, RTO, Offering, Amalgamation, TSX, Issue, Consolidation (business), Release, Security (finance)

Toronto, Ontario--(Newsfile Corp. - February 8, 2022) - Lithium Ionic Inc. ("Lithium Ionic") and POCML 6 Inc. ("POCML6", and together with Lithium Ionic, the "Issuers"), are pleased to announce that Lithium Ionic and POCML6 have closed their previously-announced brokered private placements (collectively, the "Offering") of subscription receipts (the "Subscription Receipts").

Key Points:

Toronto, Ontario--(Newsfile Corp. - February 8, 2022) - Lithium Ionic Inc. ("Lithium Ionic") and POCML 6 Inc. ("POCML6", and together with Lithium Ionic, the "Issuers"), are pleased to announce that Lithium Ionic and POCML6 have closed their previously-announced brokered private placements (collectively, the "Offering") of subscription receipts (the "Subscription Receipts").
Under the Offering, Lithium Ionic and POCML6 issued an aggregate of 20,000,000 Subscription Receipts at a price of $0.70 per Subscription Receipt (the "Issue Price") for gross proceeds of $14,000,000.
The Subscription Receipts are governed by the terms of a subscription receipt agreement in respect of the Subscription Receipts of Lithium Ionic and a subscription receipt agreement in respect of the Subscription Receipts of POCML6, each dated February 8, 2022 and among Lithium Ionic, POCML6, the Lead Agent and TSX Trust Company ("TSX Trust") (collectively, the "Subscription Receipt Agreements").
Immediately following the issuance of the Lithium Ionic Shares upon the conversion of the Subscription Receipts of Lithium Ionic, each Lithium Ionic Share will be exchanged for one common share in the Resulting Issuer (a "Resulting Issuer Share").